Adeno-associated virus site-specific integration and AAVS1 disruption

被引:46
作者
Hamilton, H
Gomos, J
Berns, KI
Falck-Pedersen, E
机构
[1] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, Hearst Res Fdn, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Mol Biol Grad Program, New York, NY 10021 USA
[3] Univ Florida, Coll Med, Gainesville, FL USA
关键词
D O I
10.1128/JVI.78.15.7874-7882.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Adeno-associated virus (AAV) is a single-stranded DNA virus with a unique biphasic lifestyle consisting of both a productive and a latent phase. Typically, the productive phase requires coinfection with a helper virus, for instance adenovirus, while the latent phase dominates in healthy cells. In the latent state, AAV is found integrated site specifically into the host genome at chromosome 19q13.4 qtr (AAVS1), the only animal virus known to integrate in a defined location. In this study we investigated the latent phase of serotype 2 AAV, focusing on three areas: AAV infection, rescue, and integration efficiency as a function of viral multiplicity of infection (MOI); efficiency of site-specific integration; and disruption of the AAVS1 locus. As expected, increasing the AAV MOI resulted in an increase in the percentage of cells infected, with 80% of cells infected at an MOI of 10. Additional MOI only marginally effected a further increase in percentage of infected cells. In contrast to infection, we found very low levels of integration at MOIs of less than 10. At an MOI of 10, at which 80% of cells are infected, less than 5% of clonal cell lines contained integrated AAV DNA. At an MOI of 100 or greater, however, 35 to 40% of clonal cell lines contained integrated AAV DNA. Integration and the ability to rescue viral genomes were highly correlated. Analysis of integrated AAV indicated that essentially all integrants were AAVS1 site specific. Although maximal integration efficiency approached 40% of clonal cell lines (essentially 50% of infected cells), over 80% of cell lines contained a genomic disruption at the AAVS1 integration locus on chromosome 19 (approximate to100% of infected cells). Rep expression by itself and in the presence of a plasmid integration substrate was able to mediate this disruption of the AAVS1 site. We further characterized the disruption event and demonstrated that it resulted in amplification of the AAVS1 locus. The data are consistent with a revised model of AAV integration that includes preliminary expansion of a defined region in AAVS1.
引用
收藏
页码:7874 / 7882
页数:9
相关论文
共 41 条
[1]   Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors [J].
Bartlett, JS ;
Wilcher, R ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2777-2785
[2]   EXPRESSION FROM THE ADENO-ASSOCIATED VIRUS-P5 AND VIRUS-P19 PROMOTERS IS NEGATIVELY REGULATED IN TRANS BY THE REP PROTEIN [J].
BEATON, A ;
PALUMBO, P ;
BERNS, KI .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4450-4454
[3]  
Berns Kenneth I., 1996, P1017
[4]   DETECTION OF ADENO-ASSOCIATED VIRUS (AAV)-SPECIFIC NUCLEOTIDE-SEQUENCES IN DNA ISOLATED FROM LATENTLY INFECTED DETROIT 6 CELLS [J].
BERNS, KI ;
PINKERTON, TC ;
THOMAS, GF ;
HOGGAN, MD .
VIROLOGY, 1975, 68 (02) :556-560
[5]   THE CRYPTIC LIFE-STYLE OF ADENOASSOCIATED VIRUS [J].
BERNS, KI ;
LINDEN, RM .
BIOESSAYS, 1995, 17 (03) :237-245
[6]   SEQUENCE AND SYMMETRY REQUIREMENTS WITHIN THE INTERNAL PALINDROMIC SEQUENCES OF THE ADENO-ASSOCIATED VIRUS TERMINAL REPEAT [J].
BOHENZKY, RA ;
LEFEBVRE, RB ;
BERNS, KI .
VIROLOGY, 1988, 166 (02) :316-327
[7]   INTEGRATION OF THE ADENO-ASSOCIATED VIRUS GENOME INTO CELLULAR DNA IN LATENTLY INFECTED HUMAN DETROIT-6 CELLS [J].
CHEUNG, AKM ;
HOGGAN, MD ;
HAUSWIRTH, WW ;
BERNS, KI .
JOURNAL OF VIROLOGY, 1980, 33 (02) :739-748
[8]   Adeno-associated virus site-specifically integrates into a muscle-specific DNA region [J].
Dutheil, N ;
Shi, F ;
Dupressoir, T ;
Linden, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (09) :4862-4866
[9]   Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].
Ferrari, FK ;
Samulski, T ;
Shenk, T ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234
[10]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532